$17.23
0.23% today
Nasdaq, Sep 03, 06:48 pm CET
ISIN
US29772L1089
Symbol
ETON

Eton Pharmaceuticals, Inc. Stock price

$17.19
+2.80 19.46% 1M
+2.16 14.37% 6M
+3.87 29.05% YTD
+12.59 273.70% 1Y
+14.87 640.95% 3Y
+9.49 123.25% 5Y
+10.94 175.04% 10Y
+10.94 175.04% 20Y
Nasdaq, Closing price Tue, Sep 02 2025
-0.12 0.69%
ISIN
US29772L1089
Symbol
ETON
Industry

Key metrics

Basic
Market capitalization
$461.0m
Enterprise Value
$465.8m
Net debt
$4.8m
Cash
$25.4m
Shares outstanding
26.8m
Valuation (TTM | estimate)
P/E
negative | 95.4
P/S
7.9 | 5.8
EV/Sales
8.0 | 5.8
EV/FCF
113.6
P/B
19.2
Financial Health
Equity Ratio
32.1%
Return on Equity
-15.7%
ROCE
-1.3%
ROIC
-
Debt/Equity
1.3
Financials (TTM | estimate)
Revenue
$58.2m | $80.1m
EBITDA
$1.9m | $20.1m
EBIT
$-807.0k | $10.3m
Net Income
$-4.1m | $4.8m
Free Cash Flow
$4.1m
Growth (TTM | estimate)
Revenue
85.4% | 105.3%
EBITDA
135.0% | 2,032.1%
EBIT
87.2% | 571.4%
Net Income
38.3% | 226.4%
Free Cash Flow
256.5%
Margin (TTM | estimate)
Gross
59.4%
EBITDA
3.2% | 25.1%
EBIT
-1.4%
Net
-7.1% | 6.0%
Free Cash Flow
7.1%
More
EPS
$-0.2
FCF per Share
$0.2
Short interest
14.0%
Employees
31
Rev per Employee
$1.3m
Show more

Is Eton Pharmaceuticals, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,011 stocks worldwide.

Eton Pharmaceuticals, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

9 Analysts have issued a Eton Pharmaceuticals, Inc. forecast:

8x Buy
89%
1x Hold
11%

Analyst Opinions

9 Analysts have issued a Eton Pharmaceuticals, Inc. forecast:

Buy
89%
Hold
11%

Financial data from Eton Pharmaceuticals, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
58 58
85% 85%
100%
- Direct Costs 24 24
86% 86%
41%
35 35
85% 85%
59%
- Selling and Administrative Expenses 30 30
55% 55%
52%
- Research and Development Expense 5.40 5.40
2% 2%
9%
1.85 1.85
135% 135%
3%
- Depreciation and Amortization 2.65 2.65
168% 168%
5%
EBIT (Operating Income) EBIT -0.81 -0.81
87% 87%
-1%
Net Profit -4.13 -4.13
38% 38%
-7%

In millions USD.

Don't miss a Thing! We will send you all news about Eton Pharmaceuticals, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Eton Pharmaceuticals, Inc. Stock News

Neutral
GlobeNewsWire
14 days ago
DEER PARK, Ill., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that members of the Company's executive leadership team will host 1x1 meetings at the 2025 Wells Fargo Healthcare Conference being held September 3-5, 20...
Neutral
Seeking Alpha
26 days ago
Eton Pharmaceuticals, Inc. (NASDAQ:ETON ) Q2 2025 Earnings Conference Call August 7, 2025 4:30 PM ET Company Participants David C. Krempa - Chief Business Officer James R.
Neutral
Seeking Alpha
26 days ago
Eton Pharmaceuticals offers GARP potential, focusing on ultra-rare disease drugs acquired at low cost, with a lean, specialized sales force and positive cash flow. My DCF model shows 80%-87% upside to fair value ($26.17) in the base case, with even higher potential in optimistic scenarios. Risks include pipeline failures and US drug price pressures, but even pessimistic scenarios suggest curren...
More Eton Pharmaceuticals, Inc. News

Company Profile

Eton Pharmaceuticals, Inc. engages in the development and commercialization of prescription drug products. It focuses on product candidates that are liquid in formulation, including injectables, oral liquids and ophthalmics. The company was founded in April 2017 and is headquartered in Deer Park, IL.

Head office United States
CEO Sean Brynjelsen
Employees 31
Founded 2017
Website etonpharma.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today